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For 25 years the early prediction of hospital mortality has
been investigated extensively in ICU patients. Assessment
of preexisting morbidities and acute physiological de-
rangements have resulted in risk-adjusted outcomes al-
lowing patient classification according to severity of
disease. This permitted the effects of different treatment
regimens to be compared more appropriately by taking
into account the presence of chronic disease states to-
gether with the importance of acute organ dysfunction at
the beginning of therapy. In addition, comparison of
outcome with risk adjustment has also been attempted
between different ICUs and between countries [1]. The
first generation of these severity scores was published
more than 20 years ago—APACHE I and II, SAPS I in
1981–1985 [2, 3, 4]—followed by the second generation
10 years later—APACHE III, SAPS II, MPM II in 1991–
1993 [1, 5, 6]. Ten years later the third generation of these
tools is knocking at the door. In Intensive Care Medicine
Metnitz, Moreno, and their colleagues [7, 8] now report
on the promising SAPS 3 system.
Including almost 20,000 patients from several hundred
ICUs from all continents, this article reports the largest
investigation of this type yet conducted. As we would
expect, patient populations are heterogeneous, and cer-
tainly ICU organization, staffing, and resources between
East and West, North, and South. Not unexpectedly,
prognostic performance of an earlier but widely used
predictive score for mortality, SAPS II, was poor. This
was true for the overall cohort and a majority of the seven
regions of the world. The new SAPS 3 ICU admission
score seems to be much better suited to predicting vital
status at hospital discharge. Customized equations were
established for specific areas of the globe, providing a real
possibility to evaluate the ICU. Therefore this study
provides data not only on outcome of patients represent-
ing a very wide range of pathologies requiring intensive
care but also on widely differing countries, thereby giving
food for thought on many questions in the field of eval-
uation of medical care. For instance, are the differences in
mortality between different continents, as well as within
Europe, real or do they merely reflect different patient
populations, comorbidities, or different therapies?
Where are we going from here? Many health care
specialists are convinced that quality assessment will be
an essential part of tomorrow’s management strategies in
all hospitals. This seems particularly valid for the most
expensive areas, including a number of high-tech and
personnel-intensive domains such as intensive care.
Transparent, objective, and precise evaluation systems of
care strategies taking into account risk adjustment and
providing outcome estimation will undoubtedly be part of
the future, and for several reasons: First, health care
providers and society want to know on what basis im-
portant investments of resources are warranted in certain
situations. Second, the ICU team will request precise
benchmarks, not only to test alternative therapeutic ap-
proaches but also to evaluate the effects of novel orga-
nizational and management strategies. Tools such as
SAPS 3 could help in the assessment of potentially re-
warding changes. Third, the differences observed in the
present investigations between different regions—and
certainly also between different ICUs in the same country
or continent—constitutes an interesting data pool which
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must be analyzed further. This could help to elucidate
which elements are associated with these differences—
most probably hospital type, and case mix, and resources
but perhaps also team organization and function, profes-
sional experience, and coverage.
More than 300 ICUs have contributed to the enormous
amount of cross-checked and reliable data collected, al-
lowing robust conclusions. Let us not stop here. The
merit of the most interesting and valuable studies is not
only their producing impressive results but their stimu-
lating further questions and research. SAPS 3 is one of
those remarkable clinical investigations—and we need to
know more about how to make all our ICUs more effi-
cient.
